CNSP analyst estimates
CNS Pharmaceuticals (CNSP) analyst ratings, the average price target and its range, and every firm's latest call.
- 0 firms rate CNSP: 0 buy, 0 hold, 0 sell.
- The average price target is $0.50 from None analysts, from $0.50 to $0.50.
CNSP analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 10, 2024 | Maxim Group | Maxim Group Upgrades CNS Pharmasceuticals Inc. (CNSP) to Buy, 'Berubicin Glioblastoma Data is Coming into View' | $0.50 |